Aptevo Therapeutics Inc.APVONASDAQ
Loading
Operating Expenses Over TimeContracting
Percentile Rank17
3Y CAGR-5.7%
5Y CAGR+13.8%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
-5.7%/yr
vs -15.9%/yr prior
5Y CAGR
+13.8%/yr
Recent deceleration
Acceleration
+10.2pp
Accelerating
Percentile
P17
Within normal range
vs 5Y Ago
1.9x
Solid growth
Streak
1 yr
Consecutive growthContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $26.63M | +9.8% |
| 2024 | $24.25M | -16.0% |
| 2023 | $28.88M | -9.1% |
| 2022 | $31.75M | -5.7% |
| 2021 | $33.69M | +141.5% |
| 2020 | $13.95M | -64.0% |
| 2019 | $38.73M | -39.0% |
| 2018 | $63.52M | -0.1% |
| 2017 | $63.60M | -6.7% |
| 2016 | $68.18M | - |